Retracted: Comparison of the Effects of Hysteroscopic Cold Broad Sword Play Combined with Estrogen and Progestin Sequential Therapy and Drospirenone and Ethinylestradiol Tablets in Patients with Severe Intrauterine Adhesion

Retracted: Comparison of the Effects of Hysteroscopic Cold Broad Sword Play Combined with Estrogen and Progestin Sequential Therapy and Drospirenone and Ethinylestradiol Tablets in Patients with Severe Intrauterine Adhesion

Bibliographic Details
Main Author:	Emergency Medicine International
Format:	Article
Language:	English
Published:	Hindawi Limited 2023-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2023/9805463

Similar Items

Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis
by: Jinghua Shi, et al.
Published: (2022-12-01)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
by: Pedro-Antonio Regidor, et al.
Published: (2023-02-01)

CARDIOPROTECTIVE PROPERTIES OF PROGESTINES: INFLUENCE OF DROSPIRENONE ON MYOCARD IN EXPERIMENTAL HEART FAILURE
by: Yu. V. Liskova, et al.
Published: (2017-07-01)

Evaluating the Cognitive Impacts of Drospirenone, a Spironolactone-Derived Progestin, Independently and in Combination With Ethinyl Estradiol in Ovariectomized Adult Rats
by: Stephanie V. Koebele, et al.
Published: (2022-05-01)

Hysteroscopic removal of intrauterine device in early pregnancy
by: Guglielmo Stabile, et al.
Published: (2022-10-01)

The Effect of a Synthetic Estrogen, Ethinylestradiol, on the hERG Block by E-4031
by: Fumiya Tamura, et al.
Published: (2021-09-01)

Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism
by: Ashley V. Ward, et al.
Published: (2022-03-01)

Is the Expression of the Components of the Carotid Matrix of Rats Influenced by Estrogen, Progestin and Tibolone?
by: Marcelo Luis Steiner, et al.
Published: (2019-08-01)

Isolated pulmonary embolism in a patient with progestin intrauterine device and factor V Leiden
by: Soluny Jean
Published: (2019-05-01)

Electrochemical degradation of 17α-ethinylestradiol: Transformation products, degradation pathways and in vivo assessment of estrogenic activity
by: Rafael Reis, et al.
Published: (2023-06-01)

Comparison of the lipophilicity parameters of drospirenone and lynestrenol
by: Agnieszka Kusztal, et al.
Published: (2022-12-01)

The benefits of estetrol addition to drospirenone for contraception
by: Jean Michel Foidart, PhD, MD, et al.
Published: (2023-11-01)

Drospirenon v evolyutsiigormonal'noy kontratseptsii
by: Elena Anatol'evna Mezhevitinova, et al.
Published: (2011-04-01)

Hysteroscopic Removal of Intrauterine Device in Pregnancy: A Scoping Review to Guide Personalized Care
by: Guglielmo Stabile, et al.
Published: (2022-11-01)

Hysteroscopic suture of levonorgestrel-releasing intrauterine system: learning curve for in vitro simulation training
by: JinCheng Huang, et al.
Published: (2023-10-01)

Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies
by: Marr J, et al.
Published: (2015-07-01)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
by: Meghan S. Perkins, et al.
Published: (2022-09-01)

Artificial intelligence-driven prognostic system for conception prediction and management in intrauterine adhesions following hysteroscopic adhesiolysis: a diagnostic study using hysteroscopic images
by: Bohan Li, et al.
Published: (2024-04-01)

Association of oxidative stress and memory performance in postmenopausal women receiving estrogen-progestin therapy
by: Shafin, Nazlahshaniza, et al.
Published: (2013)

Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
by: Emergency Medicine International
Published: (2024-01-01)

Effects of early life stage exposure of largemouth bass to atrazine or a model estrogen (17α-ethinylestradiol)
by: Jessica K. Leet, et al.
Published: (2020-10-01)

Clinical efficacy of hysteroscopic adhesiolysis combined with periodic balloon dilation for intrauterine adhesion in IVF treatment
by: Yuanhui Chen, et al.
Published: (2023-09-01)

Assessment of Risk Factors of Intrauterine Adhesions in Patients With Induced Abortion and the Curative Effect of Hysteroscopic Surgery
by: Xiaoliang Mo, et al.
Published: (2019-01-01)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
by: Anuradha Dogiparthi, et al.
Published: (2010-01-01)

Commentary on “Assessment of Risk Factors of Intrauterine Adhesions in Patients with Induced Abortion and the Curative Effect of Hysteroscopic Surgery”
by: Attilio Di Spiezio Sardo, et al.
Published: (2019-01-01)

An insight into the use of estetrol-drospirenone as effective oral contraceptive
by: Himanshu Chaudhry, et al.
Published: (2023-03-01)

Analysis of feasibility of HEOS cold knife hysteroscopic micro-shear separation in clinical treatment of patients with intrauterine adhesion
by: Gong Xishuang, Zhao Zhen, Yu Xiaoling, Jin Huimin
Published: (2023-01-01)

HYSTEROSCOPIC MYOMECTOMY
by: Ricardo Bassil Lasmar, et al.
Published: (2022-11-01)

Premenstrual syndrome: the effectiveness of treatment with a drospirenone-containing contraceptive
by: V. N. Prilepskaya, et al.
Published: (2015-12-01)

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
by: Yu-Fei Zhang, et al.
Published: (2023-04-01)

Clinical efficacy of different adjuvant treatment schemes for patients with moderate to severe intrauterine adhesions after hysteroscopic transcervical resection
by: Shi Wen, Wang Maocai, Wang Minyi, Chen Shan, Li Xiao
Published: (2022-11-01)

Influence of gender and combined estrogen–progestin oral contraceptive on parotid saliva flow rate, pH, and electrolytes concentration
by: Angela Rovera, et al.
Published: (2024-02-01)

EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation
by: Diefenbach K, et al.
Published: (2013-04-01)

CONTRACEPTION WITH DROSPIRENONE: EFFECT ON THE BODY WEIGHT AND SOME LIPID METABOLISM INDICATORS
by: A. A. Smetnik
Published: (2016-12-01)

Effect of an estetrol/drospirenone contraceptive on sexual function in women of reproductive age
by: Mekan R. Orazov, et al.
Published: (2023-04-01)

Drospirenon – gestagen KhKhI veka s antimineralokortikoidnoy aktivnost'yu
by: N M Pasman
Published: (2004-04-01)

Accuracy of a new hysteroscopic method in the assessment of tubal patency: Hysteroscopic Chromotubation
by: Burak Yucel, et al.
Published: (2018-08-01)

High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin
by: Natasa Bajalovic, et al.
Published: (2022-08-01)

High levels of progesterone receptor B in MCF-7 cells enable radical anti-tumoral and anti-estrogenic effect of progestin
by: Bajalovic, Natasa, et al.
Published: (2023)

Detecting Traces of 17α-Ethinylestradiol in Complex Water Matrices
by: Paulo M Zagalo, et al.
Published: (2020-12-01)